awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q47657861-67A708A2-738A-4191-B687-B1675CB8F814
Q47657861-67A708A2-738A-4191-B687-B1675CB8F814
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47657861-67A708A2-738A-4191-B687-B1675CB8F814
Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications.
P2860
Q47657861-67A708A2-738A-4191-B687-B1675CB8F814
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47657861-67A708A2-738A-4191-B687-B1675CB8F814
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2c6800aed9bc3055b1543bfa14a4ab86041d9f93
P2860
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.